Product Details for: Ogivri
RETURN TO SEARCH RESULTS
PRODUCT LABEL
Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
For Injection
Intravenous
420MG
Multi-Dose Vial
351(k) Biosimilar
Ogivri
Rx
002
For Injection
Intravenous
150MG
Single-Dose Vial
351(k) Biosimilar
Ogivri
Rx
Proper Name
trastuzumab-dkst
trastuzumab-dkst
Reference Product Proper Name
trastuzumab
trastuzumab
Reference Product Properietary Name
Herceptin
Herceptin
BLA Number
761074
761074
Applicant
Biocon Biologics Inc.
Biocon Biologics Inc.
Original Approval Date
December 1, 2017
December 1, 2017
Date of First Licensure